Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy
First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA)…
PMET Resources Files Amended Version of its NI 43-101 Technical Report on the CV5 Lithium-Only Feasibility Study Previously Published in 2025 on its Shaakichiuwaanaan Project
Following a routine review by the Autorité des marchés financiers ("AMF"), the…